Page last updated: 2024-08-22

gadolinium and Inappropriate GH Secretion Syndrome (Acromegaly)

gadolinium has been researched along with Inappropriate GH Secretion Syndrome (Acromegaly) in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burman, P; Edén Engström, B; Karlsson, FA; Lundin, P	1

Other Studies

1 other study(ies) available for gadolinium and Inappropriate GH Secretion Syndrome (Acromegaly)

Article	Year
Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: evaluation with serial MR. AJNR. American journal of neuroradiology, 1997, Volume: 18, Issue:4 Topics: Acromegaly; Adenoma; Adult; Aged; Antineoplastic Agents, Hormonal; Contrast Media; Drug Combinations; Evaluation Studies as Topic; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Hemorrhage; Human Growth Hormone; Humans; Image Enhancement; Insulin-Like Growth Factor I; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Necrosis; Octreotide; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Remission Induction	1997

Article

Year

Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: evaluation with serial MR.

AJNR. American journal of neuroradiology, 1997, Volume: 18, Issue:4

Topics: Acromegaly; Adenoma; Adult; Aged; Antineoplastic Agents, Hormonal; Contrast Media; Drug Combinations; Evaluation Studies as Topic; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Hemorrhage; Human Growth Hormone; Humans; Image Enhancement; Insulin-Like Growth Factor I; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Necrosis; Octreotide; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Remission Induction

1997